Evidence map›Paper›PMID 41797895›Full record

ArticleiScience2026

Distinct mutational signature and clonal evolution in constitutional mismatch repair deficiency-associated high-grade gliomas.

Chang Li, E Zeynep Erson-Omay, Yavuz Koksal, Ekrem Unal, Buket Kara, Kaya Bilguvar, Yahya Paksoy, Nimetullah Alper Durmus, Ali Kurtsoy, Huseyin Per and 3 more

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chang LiDepartment of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.
E Zeynep Erson-OmayDepartments of Neurosurgery, Yale School of Medicine, New Haven, CT 06510, USA.
Yavuz KoksalDepartments of Pediatrics, Selcuk University School of Medicine, Konya 34848, Turkiye.
Ekrem UnalPediatric Hematology and Oncology Clinic, Medical Point Hospital, Gaziantep 27584, Turkiye.
Buket KaraDepartments of Pediatrics, Selcuk University School of Medicine, Konya 34848, Turkiye.
Kaya BilguvarDepartments of Neurosurgery, Yale School of Medicine, New Haven, CT 06510, USA.
Yahya PaksoyDepartments of Radiology, Selcuk University School of Medicine, Konya 34848, Turkiye.
Nimetullah Alper DurmusDepartments of Neurosurgery, Erciyes University School of Medicine, Kayseri 38039, Turkiye.
Ali KurtsoyDepartments of Neurosurgery, Erciyes University School of Medicine, Kayseri 38039, Turkiye.
Huseyin PerDepartments of Pediatrics, Erciyes University School of Medicine, Kayseri 38039, Turkiye.
John Rosendahl ØstergaardDepartment of Pediatrics, Aarhus University Hospital, Skejby, Denmark.
Murat GünelDepartments of Neurosurgery, Yale School of Medicine, New Haven, CT 06510, USA.
Ahmet Okay ÇağlayanDepartments of Neurosurgery, Yale School of Medicine, New Haven, CT 06510, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Constitutional mismatch repair deficiency (CMMRD) is a rare cancer-predisposing syndrome. Recent studies have advanced our understanding of the genomic and epigenomic features of this disease, however, the mutational signatures and clonal evolution of CMMRD-associated high-grade gliomas (HGGs) requires further investigation. Herein, we analyzed the mutational signature and clonal evolution of 25 CMMRD-associated HGGs. Germline biallelic mutations in

Indexed as

cancermolecular biology

Identifiers

PMID41797895
PMCPMC12964222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.